GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $65,000 | – | 13,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
Perceptive Advisors | 75,000 | $860,000 | 0.09% |
HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |